Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer.
Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET scanning, and has almost twice the specificity of PET for distinguishing patients with benign lung disease from those with early stage cancer. Michael Bousamra II, MD, Associate Professor, Department of Cardiovascular and Thoracic Surgery, is presenting the results of the study at the AATS 2014 Conference on April 29, 2014.
A reliable, noninvasive diagnostic method imposes less physical and financial burden on patients who actually have no significant disease, while rapid and accurate diagnosis expedites treatment for patients who truly have lung cancer.
The team believes that while the breath test would not replace CT as a primary screening tool, it would be particularly helpful in conjunction with a positive CT scan result. “This breath analysis method presents the potential for a cheaper and more reliable diagnostic option for patients found to have bulky disease on a CT scan. If the breath analysis is negative, the patient may, in some instances, be followed with repeated exams without necessitating a biopsy. But a positive breath analysis would indicate that the patient may proceed to definitive biopsy, thus expediting treatment,” says Dr. Bousamra.
Investigators used specially coated silicon microchips to collect breath samples from 88 healthy controls, 107 patients with lung cancer, 40 individuals with benign pulmonary disease, and 7 with metastatic lung cancer.
Previous work had pinpointed four specific substances, known as carbonyl compounds, in breath samples as “elevated cancer markers” (ECMs) that distinguish patients with lung cancer from those with benign disease. The carbonyl compounds found in the breath are thought to reflect chemical reactions occurring in malignant lung tumors. In this study, the authors compared the findings from the breath analyses to the results from PET scans.
The investigators found that the sensitivity and specificity of breath analysis depended upon how many of the ECMs were elevated. For example, having 3 or 4 ECMs was diagnostic of lung cancer in 95% of those with this result. The majority of patients with benign pulmonary disease had either 0 or 1 ECM, while those with Stage IV cancer were most likely to have 3 or 4. The number of ECMs could be used to differentiate benign disease from both early and advanced stage lung cancer. Interestingly, 3 of the 4 elevated markers returned to normal levels after cancer resection.
When it comes to differentiating early stage lung cancer from benign pulmonary disease, breath analysis and PET scanning had similar sensitivities (82.8% and 90.3%, respectively). However, breath analysis had a much higher specificity than PET (75% vs. 38.7%, respectively) for distinguishing benign disease, which means that it was much more accurate at identifying those who did not have cancer. This would be an important feature for patients with benign disease, since having a breath analysis rather than PET scan could mean avoiding an unnecessary invasive biopsy procedure later on.
The Latest on: Detect Early Lung Cancer
via Google News
The Latest on: Detect Early Lung Cancer
- Early Signs of Lung Cancer and Why Screening Is Importanton June 18, 2021 at 6:00 am
Lung cancer is the No. 1 cause of death by cancer in both men and women in the U.S., accounting for about 25% of all deaths from cancer, according to the American Cancer Society. There are more people ...
- Atrium Health doctors use artificial intelligence and robots to help detect lung cancer earlyon June 17, 2021 at 4:00 pm
Doctors at Atrium Health are using artificial intelligence and robots to help them detect lung cancers at an earlier stage.
- Ground-breaking trial pilots new tests to detect lung cancer earlieron June 17, 2021 at 6:16 am
The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable.
- A new blood test can now detect multiple cancer types earlyon June 16, 2021 at 8:56 am
There is a new test that can detect more than 50 types of cancers even at early stages. The Galleri (Gallery) test is intended for those at an elevated risk of cancer, such as adults aged 50 and older ...
- Lung Cancer: Screening before it's too lateon June 16, 2021 at 8:42 am
Recognized for its expertise in the field of lung cancer, the McGill University Health Centre (MUHC) is one of eight hospitals designated by the Ministère de la Santé et des Services sociaux (MSSS) to ...
- Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Canceron June 14, 2021 at 7:52 am
NEW YORK – Genecast said on Monday that it will launch a clinical trial to assess whether its qPCR-based liquid biopsy test can detect EGFR mutations in early-stage non-small cell lung cancer, or ...
- Singapore firm that developed COVID-19 breath test pivoted from detecting lung cancer to coronaviruson June 14, 2021 at 3:20 am
SINGAPORE: When COVID-19 hit Singapore early last year, local start-up Breathonix had to stop all its clinical trials for its lung cancer ...
- GENECAST begins clinical research on early diagnosis of lung cancer with Samsung Medical Centeron June 14, 2021 at 3:00 am
On June 14, GENECAST (CEO, SeungChan Baek), a specialist in liquid biopsy-based cancer diagnostics, announced that it will begin a clinical study for the early diagnosis of non-small cell lung cancer ...
- People in Yorkshire invited for new diagnostic test at University of Leeds which could improve lung cancer survival chanceson June 11, 2021 at 2:35 am
A new test is being trialled at the University of Leeds in a bid to improve the early diagnosis of lung cancer which could increase the survival chances of patients.
- Researchers pilot new tests for early detection of lung cancer in Southamptonon June 11, 2021 at 1:30 am
The first participants have taken part in a new research trial that aims to save lives by improving the early diagnosis of lung cancer. People attending the NHS Targeted Lung Health Checks in ...
via Bing News